Inhibitive effect of SEB-scFv fusion protein on gastric cancer
- VernacularTitle:抗胃癌MG7单链抗体与重组超抗原SEB融合蛋白在体内外对胃癌细胞的杀伤作用研究
- Author:
Qiang TONG
;
Ke LIU
;
Xiaogang SHU
;
Xiaoming LU
;
Kaixiong TAO
;
Guobin WANG
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Cell apoptosis;
Recombinant fusion proteins;
Antigens
- From:
Chinese Journal of General Surgery
2008;23(4):296-299
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the antitumor effect of SEB-scFv fusion Drotein on gastric cancer. Methods Typical changes of morphologic features and super-microstructure were observed when SEB-scFv fusion protein was used in SGC7901 cens;and the effects of SEB-scFv and its concentration on the cell growth were examined by methyltetrazolium(MTT)assay;DNA ladder and flow cytometry were employed respectively to detect the inhibition phenomenon or apoptosis.We produced a subcutaneous gastric tumor model in baby SD rats by implanting SGC7901 cells.The SEB and SEB-scFv were injeeted to the vena caudalis in the trial groups,and normal saline to the control group.The weight of the tumor and the survival were recorded after treatment. Results Cell inhibitory rate was increased along with increased concentration of SEB-scFv fusion protein.Electron microscopy revealed that the cell presented typical changes of apoptosis.FCM indicated that the apoptotic rate of SGC7901 cell lines significantly increased with increasing dose of SEB-scFv fusion protein,and agarose gel electrophoresis appeared marked DNA ladder.The average weight of tumor in the SEB-scFv group was lower than that in control groups(P＜0.05).The tumor inhibition rate was 61.3%,and the mean survival period of rats in SEB-scFv group was longer than that of other group(P＜0.05)with a survival prolongation rate of 54.6%. Conclusion The resuhs indicate that SEB-scFv fusion protein has an obvious antitumor effect on gastric cancer.
